← All trials
NCT04715997
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 30, 2020
- Primary completion
- May 30, 2021
- Completion date
- Mar 30, 2022
- First posted
- Jan 20, 2021
- Last posted
- Jan 20, 2021
- Enrollment
- 170
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Genexine, Inc.Lead sponsor
- Yonsei UniversityOverall official - principal investigator
- Genexine, Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.